4//SEC Filing
Hardy Alexander 4
Accession 0001048477-25-000027
CIK 0001048477other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:17 PM ET
Size
8.2 KB
Accession
0001048477-25-000027
Insider Transaction Report
Form 4
Hardy Alexander
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-03-17+44,360→ 175,583 total - Tax Payment
Common Stock
2025-03-14$69.44/sh−2,933$203,668→ 131,223 total - Award
Stock Option (Right to Buy Common Stock)
2025-03-17+61,750→ 61,750 totalExercise: $71.55From: 2026-03-17Exp: 2035-03-16→ Common Stock (61,750 underlying)
Footnotes (2)
- [F1]Restricted stock units granted March 17, 2025. Price not applicable.
- [F2]Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0002001910
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 6:17 PM ET
- Size
- 8.2 KB